Smacked a good 20% due to no real positive news. Simply hype without confirmation.
- where is FDA acceptance of Volpara technology?
- what happened to the SaaS launch?
- are there major new contracts in the pipeline?
- is expansion on the cards?
Delays are causing investors to bail.
This isn't a PME, but isn't far behind. If a company can keep shares on issue low, it knows how to manage its capital.
General Discussion, page-208
Add VHT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.15 |
Change
0.000(0.00%) |
Mkt cap ! $291.2M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
| VHT (ASX) Chart |
Day chart unavailable